Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Salmon M, White HE, Zizkova H, Gottschalk A, Motlova E, Cerveira N, Colomer D, Coriu D, Franke GN, Gottardi E, Izzo B, Jurcek T, Lion T, Schäfer V, Venturi C, Vigneri P, Zawada M, Zuna J, Hovorkova L, Koblihova J, Klamova H, Markova MS, Srbova D, Benesova A, Polivkova V, Zackova D, Mayer J, Roeder I, Glauche I, Ernst T, Hochhaus A, Polakova KM, Cross NCP. Salmon M, et al. Among authors: markova ms. Leukemia. 2022 Jul;36(7):1879-1886. doi: 10.1038/s41375-022-01612-2. Epub 2022 Jun 8. Leukemia. 2022. PMID: 35676453 Free PMC article.
Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
Nemeckova S, Alexova-Zurkova K, Hainz P, Krystofova J, Mackova J, Roubalova K, Stastna-Markova M, Vrana M, Vydra J. Nemeckova S, et al. Among authors: stastna markova m. Curr Oncol. 2022 Apr 20;29(5):2928-2934. doi: 10.3390/curroncol29050239. Curr Oncol. 2022. PMID: 35621629 Free PMC article.
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS.
Kaisrlikova M, Vesela J, Kundrat D, Votavova H, Dostalova Merkerova M, Krejcik Z, Divoky V, Jedlicka M, Fric J, Klema J, Mikulenkova D, Stastna Markova M, Lauermannova M, Mertova J, Soukupova Maaloufova J, Jonasova A, Cermak J, Belickova M. Kaisrlikova M, et al. Among authors: stastna markova m. Leukemia. 2022 Jul;36(7):1898-1906. doi: 10.1038/s41375-022-01584-3. Epub 2022 May 3. Leukemia. 2022. PMID: 35505182 Free PMC article.
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.
Kaisrlikova M, Kundrat D, Koralkova P, Trsova I, Lenertova Z, Votavova H, Merkerova MD, Krejcik Z, Vesela J, Vostry M, Simeckova R, Markova MS, Lauermannova M, Jonasova A, Cermak J, Divoky V, Belickova M. Kaisrlikova M, et al. Among authors: markova ms. Int J Cancer. 2024 May 1;154(9):1652-1668. doi: 10.1002/ijc.34834. Epub 2024 Jan 5. Int J Cancer. 2024. PMID: 38180088
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission.
Machova Polakova K, Zizkova H, Zuna J, Motlova E, Hovorkova L, Gottschalk A, Glauche I, Koblihova J, Pecherkova P, Klamova H, Stastna Markova M, Srbova D, Benesova A, Polivkova V, Jurcek T, Zackova D, Mayer J, Ernst T, Mahon FX, Saussele S, Roeder I, Cross NCP, Hochhaus A. Machova Polakova K, et al. Among authors: stastna markova m. Leukemia. 2020 Aug;34(8):2113-2124. doi: 10.1038/s41375-020-0882-1. Epub 2020 May 29. Leukemia. 2020. PMID: 32472084
Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT.
Šťastná-Marková M, Hamšíková E, Hainz P, Hubáček P, Kroutilová M, Kryštofová J, Ludvíková V, Musil J, Pecherková P, Saláková M, Šroller V, Vydra J, Němečková Š. Šťastná-Marková M, et al. Vaccines (Basel). 2021 Oct 22;9(11):1226. doi: 10.3390/vaccines9111226. Vaccines (Basel). 2021. PMID: 34835157 Free PMC article.
Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Macková J, Hainz P, Kryštofová J, Roubalová K, Šťastná-Marková M, Vaníková Š, Musil J, Vydra J, Němečková Š. Macková J, et al. Among authors: stastna markova m. Leuk Res. 2023 Jul;130:107314. doi: 10.1016/j.leukres.2023.107314. Epub 2023 May 16. Leuk Res. 2023. PMID: 37216792 Free PMC article.